MedPath

A new dietary intervention for children with hypothalamic obesity after treatment for a craniopharyngioma: a pilot-study

Completed
Conditions
Hypothalamic Obesity
10021112
10003018
Registration Number
NL-OMON46114
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
6
Inclusion Criteria

- Children or adolescents with hypothalamic obesity, BMI > 1,9 SD, currently visiting a pediatric endocrinologist after treatment for sellar or suprasellar lesions are eligible for this study.
- patients must be in complete remission or have residual disease > 1 year

Exclusion Criteria

- Children < age of 5 years
- Current progression of disease.
- Diabetes Mellitus type 1

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>BMI (before, during and after cessation of the intervention)<br /><br><br /><br>The criteria for success regarding feasibility of this pilot study are:<br /><br>- At least 70% of all eligible subjects can be recruited<br /><br>- Completion of intervention in at least 80% of subjects included<br /><br><br /><br>The criteria for success regarding efficiency of this pilot study is:<br /><br>- 80% of subjects show weight reduction or stabilisation during the 1 year<br /><br>intervention period</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes:<br /><br>- The Quality of Life (measured with PedsQL)<br /><br>- The effect of the intervention on the metabolic profile (i.e. blood pressure,<br /><br>cholesterol profile, glycemic control)<br /><br>- Physical activity (measured with GENEactiv wristband and HAES 1.6<br /><br>questionnaire)<br /><br>- The correlation between daily activity measured by the HAES questionnaire and<br /><br>the GENEActiv wristband</p><br>
© Copyright 2025. All Rights Reserved by MedPath